Showing posts with label towards. Show all posts
Showing posts with label towards. Show all posts

Thursday, 5 September 2013

Should our attitude towards 'never events' change?

surgery There are twenty-five errors in the NHS that are classed as 'never events', including wrong site surgery and retained foreign objects. Photograph: Sean Smith/The Guardian

Twenty-five errors in the health service are considered so intolerable and inexcusable that they have been designated 'never events'. They include wrong-site surgery, retained foreign objects and administering chemotherapy by the wrong route.

When a never event occurs, the organisation concerned must follow national procedures for reporting and investigating what happened and may pay a significant financial penalty. The object of the policy introduced in 2009 is to encourage greater organisational focus on specific serious safety issues. The problem with categorising certain incidents as never events is that it may divert attention from the most important goal of improving patient safety across the board. The term is also misleading because these events do occur, usually because of a combination of chance and human error, factors that can never be totally eliminated. In his positively received report into NHS patient safety Professor Don Berwick states: "'Zero Harm' is a bold and worthy aspiration, [but] the scientifically correct goal is 'continual reduction'. All in the NHS should understand that safety is a continually emerging property, and that the battle for safety is never 'won'; rather, it is always in progress."

In May 2013 a BBC investigation identified 762 never events in four years, including 322 retained items and 73 misplaced nasogastric feeding tubes. I do not believe the categorisation never events is helpful. This is not to dismiss the distress these errors cause to patients and their families, but the term and the financial penalties create a stigma for individuals and organisations, which may not be conducive to a culture that should promote reporting and learning from mistakes. When our members, who are 50% of UK GPs and hospital doctors, approach us for advice about what to do if there has been a mistake in a patient's care or treatment, we advise them to ensure the patient receives a sincere apology, together with an explanation of what went wrong and how it will be put right. Irrespective of whether the incident was a never event, it is vital that there is a full investigation and that steps are taken to avoid the incident happening again.

For patients who are harmed, the last thing on their minds is probably whether it was a never event. There are incidents in which patients are harmed that fall outside the classification. One example is where patients have been given a drug, such as penicillin, to which they have a known allergy. The consequences of this could be anaphylactic shock and even death and in many cases the error could have been prevented by taking and recording of a medical history, checking records before administering medication and checking if the patient is wearing a red wristband. These preventable errors must be treated as seriously as a never event but there is a risk they may not get the same attention.

Medicine, even when properly and carefully practised, is not a zero-harm or a zero-risk profession.

Preventable things can and do go wrong, sometimes with severe consequences for patients and to the distress of the healthcare professionals involved.

Berwick argues there is a need for a transparent culture within the NHS where mistakes are reported and learning is shared to improve patient safety. Patients who have suffered harm because of any medical error should rightly expect that what happened to them has been the subject of a thorough investigation to determine what happened, why and what lessons have to be learned. Wouldn't it be better to concentrate on this than on determining whether an incident classifies as a never event?

Dr Christine Tomkins is chief executive of the MDU

This article is published by Guardian Professional. Join the Healthcare Professionals Network to receive regular emails and exclusive offers.


View the original article here

Friday, 26 July 2013

Treating people who use drugs is the first step towards eliminating hepatitis C - international guidelines for treatment released today

Main Category: Liver Disease / Hepatitis
Also Included In: Alcohol / Addiction / Illegal Drugs
Article Date: 25 Jul 2013 - 1:00 PDT Current ratings for:
Treating people who use drugs is the first step towards eliminating hepatitis C - international guidelines for treatment released today
not yet ratednot yet rated

The burden of liver disease could be dramatically reduced by increasing treatment for hepatitis C infection among people who inject drugs, suggest new recommendations developed by researchers from the Kirby Institute at UNSW, in collaboration with colleagues from the International Network on Hepatitis Care in Substance Users (INHSU).

In Australia, 226,000 people are living with chronic hepatitis C and over 10,000 new cases are reported every year. Hepatitis C can lead to serious liver complications such as liver failure or cancer, which are associated with considerable costs to the health care system. Although almost 80 per cent of all infections occur among people who inject drugs, only one per cent of these people currently receive treatment.

"Treatment for hepatitis C infection among people who inject drugs remains unacceptably low," said Dr Jason Grebely, Senior Lecturer at the Kirby Institute, UNSW, and co-lead author of the recommendations. "Clinicians have been hesitant to recommend treatment in this population because of a lack of understanding about how lifestyle factors may impede successful treatment."

But research supporting the first set of international recommendations ever released for treating hepatitis C in people who inject drugs has shown that treatment can be very successful when barriers are addressed within a supportive environment.

"Reducing the significant burden of liver disease related to hepatitis C in Australia and internationally will require improved assessment and treatment of the population most affected: people who currently inject drugs and those who have injected drugs in the past," says Philip Bruggmann, President of INHSU. "By providing appropriate care to this group, we can reduce the burden of hepatitis C-related liver disease in this vulnerable population and slow the spread of this world-wide epidemic. These new recommendations serve as a first step towards elimination of hepatitis C."

The global recommendations are published online today in the journal Clinical Infectious Diseases ahead of World Hepatitis Day on July 28. They are part of a supplement entitled "Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward", developed in collaboration with INHSU.

Additional Stakeholder Comments:

"These are exceptionally positive and welcome findings. Following the listing of new hep C treatments for subsidy by the Australian Government in April, almost all people in Australia living with hepatitis C in Australia can enjoy cure rates of around 75 to 80 per cent. This new evidence shows us that people who have been least able to access treatment in the past, can and should be able to benefit from these new treatment advances."

Stuart Loveday
CEO of Hepatitis NSW

"This report is most welcomed. It finally provides the much needed endorsement that peer support requires to validate it as an efficacious treatment modality. That combined with the recognition that people who continue to inject or use drugs can access treatment will mean that more people will be able to access treatment. For too long those most affected by hepatitis C have been on the periphery, this report puts them where they belong - front and centre."

Nicky Bath
CEO of the NSW Users and AIDS Association

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our liver disease / hepatitis section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Institute, Kirby. "Treating people who use drugs is the first step towards eliminating hepatitis C - international guidelines for treatment released today." Medical News Today. MediLexicon, Intl., 25 Jul. 2013. Web.
26 Jul. 2013. APA
Institute, K. (2013, July 25). "Treating people who use drugs is the first step towards eliminating hepatitis C - international guidelines for treatment released today." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/263862.php.

Please note: If no author information is provided, the source is cited instead.


'Treating people who use drugs is the first step towards eliminating hepatitis C - international guidelines for treatment released today'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Treating people who use drugs is the first step towards eliminating hepatitis C - international guidelines for treatment released today

Main Category: Liver Disease / Hepatitis
Also Included In: Alcohol / Addiction / Illegal Drugs
Article Date: 25 Jul 2013 - 1:00 PDT Current ratings for:
Treating people who use drugs is the first step towards eliminating hepatitis C - international guidelines for treatment released today
not yet ratednot yet rated

The burden of liver disease could be dramatically reduced by increasing treatment for hepatitis C infection among people who inject drugs, suggest new recommendations developed by researchers from the Kirby Institute at UNSW, in collaboration with colleagues from the International Network on Hepatitis Care in Substance Users (INHSU).

In Australia, 226,000 people are living with chronic hepatitis C and over 10,000 new cases are reported every year. Hepatitis C can lead to serious liver complications such as liver failure or cancer, which are associated with considerable costs to the health care system. Although almost 80 per cent of all infections occur among people who inject drugs, only one per cent of these people currently receive treatment.

"Treatment for hepatitis C infection among people who inject drugs remains unacceptably low," said Dr Jason Grebely, Senior Lecturer at the Kirby Institute, UNSW, and co-lead author of the recommendations. "Clinicians have been hesitant to recommend treatment in this population because of a lack of understanding about how lifestyle factors may impede successful treatment."

But research supporting the first set of international recommendations ever released for treating hepatitis C in people who inject drugs has shown that treatment can be very successful when barriers are addressed within a supportive environment.

"Reducing the significant burden of liver disease related to hepatitis C in Australia and internationally will require improved assessment and treatment of the population most affected: people who currently inject drugs and those who have injected drugs in the past," says Philip Bruggmann, President of INHSU. "By providing appropriate care to this group, we can reduce the burden of hepatitis C-related liver disease in this vulnerable population and slow the spread of this world-wide epidemic. These new recommendations serve as a first step towards elimination of hepatitis C."

The global recommendations are published online today in the journal Clinical Infectious Diseases ahead of World Hepatitis Day on July 28. They are part of a supplement entitled "Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward", developed in collaboration with INHSU.

Additional Stakeholder Comments:

"These are exceptionally positive and welcome findings. Following the listing of new hep C treatments for subsidy by the Australian Government in April, almost all people in Australia living with hepatitis C in Australia can enjoy cure rates of around 75 to 80 per cent. This new evidence shows us that people who have been least able to access treatment in the past, can and should be able to benefit from these new treatment advances."

Stuart Loveday
CEO of Hepatitis NSW

"This report is most welcomed. It finally provides the much needed endorsement that peer support requires to validate it as an efficacious treatment modality. That combined with the recognition that people who continue to inject or use drugs can access treatment will mean that more people will be able to access treatment. For too long those most affected by hepatitis C have been on the periphery, this report puts them where they belong - front and centre."

Nicky Bath
CEO of the NSW Users and AIDS Association

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our liver disease / hepatitis section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Institute, Kirby. "Treating people who use drugs is the first step towards eliminating hepatitis C - international guidelines for treatment released today." Medical News Today. MediLexicon, Intl., 25 Jul. 2013. Web.
26 Jul. 2013. APA
Institute, K. (2013, July 25). "Treating people who use drugs is the first step towards eliminating hepatitis C - international guidelines for treatment released today." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/263862.php.

Please note: If no author information is provided, the source is cited instead.


'Treating people who use drugs is the first step towards eliminating hepatitis C - international guidelines for treatment released today'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here